Journal
ANALYTICAL CHEMISTRY
Volume 94, Issue 32, Pages 11175-11184Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.2c01433
Keywords
-
Categories
Funding
- NSF [CHE-2203602]
- Robert A. Welch Foundation [F-1155]
- UT System
Ask authors/readers for more resources
With the rapid development of new biotherapeutics, it is crucial to ensure consistent quality and understand degradation pathways. This study presents a comprehensive mass spectrometry approach to analyze the sequences and structures of selenoproteins, as well as discover unknown by-products.
With the rapid acceleration in the design and development of new biotherapeutics, ensuring consistent quality and understanding degradation pathways remain paramount, requiring an array of analytical methods including mass spectrometry. The incorporation of non-canonical amino acids, such as for synthetic selenoproteins, creates additional challenges. A comprehensive strategy to characterize selenoproteins should serve dual purposes of providing sequence confirmation and mapping of selenocysteine bridge locations and the identification of unanticipated side products. In the present study, a combined approach exploiting the benefits of both top-down and bottom-up mass spectrometry was developed. Both electron-transfer/higher-energy collision dissociation and 213 urn ultraviolet photodissociation were utilized to provide complementary information, allowing high quality characterization, localization of diselenide bridges for complex proteins, and the identification of previously unreported selenoprotein dieters.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available